New painkiller aims to cut opioid use after shoulder surgery
NCT ID NCT07280195
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a medication applied directly during shoulder replacement surgery (ZYNRELEF) can reduce the need for strong painkillers after the operation, compared to the standard method of using a nerve block with a catheter. About 86 adults having shoulder replacement will be randomly assigned to one of the two pain management approaches. Researchers will track how much opioid medication each group uses, their pain scores, and satisfaction with pain control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can patients safely dispense their own pain medicine after surgery?
- Parkinson's pain: could a new Add-On drug bring relief?
- Can pictures capture how chronic pain disrupts daily life?
- Could a simple choice sheet curb unneeded opioid prescriptions?
- Can a Pen-Like device make Kids' dental shots painless?